Challenges associated with CAR-T cells in solid tumors

preview_player
Показать описание
Thaddäus Strzalkowski, Ludwig-Maximilians-Universität München, Munich, Germany, discusses the challenges associated with CAR-T cell sin solid tumors, including suppression of CAR-T cells by the tumor microenvironment, impairing lytic capacity. This interview took place at the Immunotherapy of Cancer (ITOC) Conference 2022 in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
  1. VJOncology
  2. Speaker: Thaddäus Strzalkowski
  3. Event: ITOC 2022
  4. Format: Interview
  5. Subject: General
  6. Field: Immuno-Oncology
Рекомендации по теме
Challenges associated with 0:01:28

Challenges associated with CAR-T cells in solid tumors

Challenges associated with 0:01:42

Challenges associated with CAR-T cell production

Challenges in CAR 0:03:12

Challenges in CAR T-cell therapy

CAR T-cell therapies: 0:04:28

CAR T-cell therapies: selecting patients & associated challenges

Current challenges in 0:04:22

Current challenges in CAR-T cell therapy and the role of the tumor microenvironment

CAR-T in solid 0:01:19

CAR-T in solid tumors: challenges and future directions

The challenges in 0:01:49

The challenges in implementing CAR-T cell therapy for the treatment of solid tumors

Current challenges faced 0:06:22

Current challenges faced with CAR T-cell therapies

Dr. Brentjens on 0:01:22

Dr. Brentjens on CAR T-Cell Therapy Challenges

Advancements and challenges 0:02:53

Advancements and challenges in CAR-T cell therapy

Challenges after CAR 0:01:51

Challenges after CAR T-cell therapy

Challenges With CAR 0:01:32

Challenges With CAR T-Cell Therapy

Dr. Roboz on 0:01:33

Dr. Roboz on Challenges With CAR T-cell Therapy in ALL

Dr. Shaughnessy on 0:01:42

Dr. Shaughnessy on Addressing Challenges With CAR T-Cell Therapy in Hematologic Malignancies

Challenges of CAR 0:01:16

Challenges of CAR T-cells in solid tumors

CAR-T cells: challenges 0:03:25

CAR-T cells: challenges and opportunities

Current challenges with 0:02:47

Current challenges with CAR T-cell therapy

Challenges to Overcome 0:01:29

Challenges to Overcome With CAR T-Cell Therapy for Acute Myeloid Leukemia

Current challenges in 0:02:36

Current challenges in targeting solid tumors with CAR T-cells

Regulatory and commercialization 0:01:51

Regulatory and commercialization challenges with CAR T-cell therapy

The challenges of 0:04:10

The challenges of CAR T-cell therapy for pediatric B-ALL

Challenges with CAR 0:01:51

Challenges with CAR T-cell therapy

Challenges in developing 0:02:44

Challenges in developing CAR-T cells for liver cancer

Challenges of dual-targeted 0:01:13

Challenges of dual-targeted CAR T-cell therapy